Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

Journal article

Amegadzie JE. et al, (2024), Thorax, 79, 718 - 724

Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19.

Journal article

Cass SP. et al, (2024), ERJ open research, 10, 919 - 2023

Development and validation of a new algorithm for improved cardiovascular risk prediction

Journal article

Hippisley-Cox J. et al, (2024), Nature Medicine, 30, 1440 - 1447

Inhaled corticosteroids for the treatment of COVID-19.

Journal article

Bafadhel M. et al, (2022), European respiratory review : an official journal of the European Respiratory Society, 31

Moving the pathway goalposts: COPD as an immune-mediated inflammatory disease.

Journal article

Cass SP. et al, (2022), The Lancet. Respiratory medicine, 10, 1110 - 1113

Discordant diagnostic criteria for pneumonia in COPD trials: a review

Journal article

Wise RA. et al, (2021), European Respiratory Review, 30, 210124 - 210124

A new piece in the puzzle: the eosinophil and the development of COPD

Journal article

Petousi N. et al, (2021), European Respiratory Journal, 58, 2101105 - 2101105

Renaming COPD exacerbations: the UK respiratory nursing perspective.

Journal article

Mwasuku C. et al, (2021), BMC pulmonary medicine, 21

Predicting treatment outcomes following an exacerbation of airways disease

Journal article

Halner A. et al, (2021), PLOS ONE, 16, e0254425 - e0254425

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Journal article

Ramakrishnan S. et al, (2021), The Lancet. Respiratory medicine

Finding the true prevalence of obstructive lung disease: two steps forward and one step back

Journal article

Russell REK. and Wang K., (2020), European Respiratory Journal, 55, 2001514 - 2001514

The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach

Journal article

Ramakrishnan S. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 201, 1441 - 1443

Load More